Implementation of an adapted Sepsis Risk Calculator algorithm to reduce antibiotic usage in the management of early onset neonatal sepsis: a multicentre initiative in Wales, UK.


Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
May 2022
Historique:
received: 22 12 2020
accepted: 06 08 2021
pubmed: 24 9 2021
medline: 23 4 2022
entrez: 23 9 2021
Statut: ppublish

Résumé

Assess the impact of introducing a consensus guideline incorporating an adapted Sepsis Risk Calculator (SRC) algorithm, in the management of early onset neonatal sepsis (EONS), on antibiotic usage and patient safety. Multicentre prospective study SETTING: Ten perinatal hospitals in Wales, UK. All live births ≥34 weeks' gestation over a 12-month period (April 2019-March 2020) compared with infants in the preceding 15-month period (January 2018-March 2019) as a baseline. The consensus guideline was introduced in clinical practice on 1 April 2019. It incorporated a modified SRC algorithm, enhanced in-hospital surveillance, ongoing quality assurance, standardised staff training and parent education. The main outcome measure was antibiotic usage/1000 live births, balancing this with analysis of harm from delayed diagnosis and treatment, disease severity and readmissions from true sepsis. Outcome measures were analysed using statistical process control charts. Proportion of antibiotic use in infants ≥34 weeks' gestation. 4304 (14.3%) of the 30 105 live-born infants received antibiotics in the baseline period compared with 1917 (7.7%) of 24 749 infants in the intervention period (45.5% mean reduction). All 19 infants with culture-positive sepsis in the postimplementation phase were identified and treated appropriately. There were no increases in sepsis-related neonatal unit admissions, disease morbidity and late readmissions. This multicentre study provides evidence that a judicious adaptation of the SRC incorporating enhanced surveillance can be safely introduced in the National Health Service and is effective in reducing antibiotic use for EONS without increasing morbidity and mortality.

Identifiants

pubmed: 34551917
pii: archdischild-2020-321489
doi: 10.1136/archdischild-2020-321489
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

303-310

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Nitin Goel (N)

Department of Neonatal Medicine, University Hospital of Wales, Cardiff, UK.

Stephanie Cannell (S)

Department of Neonatal Medicine, Singleton Hospital, Swansea, UK.

Gemma Davies (G)

Department of Neonatal Medicine, Singleton Hospital, Swansea, UK.

Murali Sridhar Natti (MS)

Department of Neonatal Medicine, Royal Gwent Hospital, Newport, UK.

Vickness Kirupaalar (V)

Department of Paediatrics, Princess of Wales Hospital, Bridgend, UK.

Artur Abelian (A)

Department of Paediatrics, Wrexham Maelor Hospital, Wrexham, UK.

Shakir Saeed (S)

Department of Paediatrics, Ysbyty Gwynedd, Bangor, Gwynedd, UK.

Rhian Smith (R)

Department of Neonatal Medicine, Glan Clwyd Hospital, Rhyl, Denbighshire, UK.

Ravi Manikonda (R)

Department of Paediatrics, Nevill Hall Hospital, Abergavenny, UK.

Prem Kumar Pitchaikani (PK)

Department of Paediatrics, Glangwili General Hospital, Carmarthen, Carmarthenshire, UK.

Dawn Davies (D)

Department of Paediatrics, Bronglais General Hospital, Aberystwyth, Ceredigion, UK.

Rachel May Morris (RM)

Department of Neonatal Medicine, University Hospital of Wales, Cardiff, UK.

Lynsey Edwards (L)

Department of Neonatal Medicine, University Hospital of Wales, Cardiff, UK.

Roopashree Govindaraju (R)

Department of Neonatal Medicine, Royal Gwent Hospital, Newport, UK.

Kate Creese (K)

Department of Paediatrics, Princess of Wales Hospital, Bridgend, UK.

Jane Jones (J)

Department of Paediatrics, Wrexham Maelor Hospital, Wrexham, UK.

Jalil Choudhary (J)

Department of Paediatrics, Ysbyty Gwynedd, Bangor, Gwynedd, UK.

Sarah Rowley (S)

Department of Neonatal Medicine, University Hospital of Wales, Cardiff, UK.

Chidambaram Sethuraman (C)

Department of Neonatal Medicine, Royal Gwent Hospital, Newport, UK.

Helen Muxworthy (H)

Department of Women's Health, Singleton Hospital, Swansea, UK.

Felicity Curtis (F)

Department of Women's Health, Singleton Hospital, Swansea, UK.

Patricia Donnelly (P)

Department of Paediatrics, Princess of Wales Hospital, Bridgend, UK.

Manohar Joishy (M)

Department of Paediatrics, Ysbyty Gwynedd, Bangor, Gwynedd, UK.

Ian Barnard (I)

Department of Neonatal Medicine, Glan Clwyd Hospital, Rhyl, Denbighshire, UK.

Celyn Kenny (C)

Department of Neonatal Medicine, University Hospital of Wales, Cardiff, UK.

Rajarshi Pal (R)

Department of Paediatrics, Glangwili General Hospital, Carmarthen, Carmarthenshire, UK.

Karen Jones (K)

Department of Paediatrics, Glangwili General Hospital, Carmarthen, Carmarthenshire, UK.

Sujoy Banerjee (S)

Department of Neonatal Medicine, Singleton Hospital, Swansea, UK sujoy.banerjee@wales.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH